News & Coverage

Article Image

Somerville City Council, mayor support decriminalization of psychedelic plants

Though Somerville cannot decriminalize these plants locally, they are calling on law enforcement to make this the lowest priority.
Wicked Local

Jan 19, 2021
Article Image

Psychedelic Therapy Schools Are Popping Up Like Mushrooms

For hundreds or thousands of dollars, you can get certified to administer mind-altering—and some say, mind-healing—drugs.
Bloomberg

Jan 19, 2021
Article Image

PSYC Completes Execution of JV Partnership with Digital Mental Health Startup, PsycheDev Inc.

Global Trac Solutions, Inc. (OTCPink: PSYC) ("Global" "PSYC" or the "Company") a digital media leader within the emerging sector of medicinal psychedelics, is pleased to announce that the Company has ...
MarketWatch

Jan 19, 2021
Article Image

Silo Pharma to Participate in Virtual Conference on Investing in Psychedelics

NEW JERSEY , Jan. 19, 2021 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (OTCQB: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic ... in the ...
Associated Press

Jan 19, 2021
Article Image

I Was a Mormon. Then I Found Psychedelics.

Brandon with an Amanita muscaria he found in New Zealand. Ahe he said: "The colour, wrinkles and metallic sheen resemble Joseph Smith's description of "the Golden Plates" which he claimed were the ...
VICE

Jan 19, 2021
Article Image

NeonMind Lists on the Frankfurt Stock Exchange

Vancouver, British Columbia–(Newsfile Corp. – January 19, 2021) – NeonMind Biosciences Inc. (CSE: NEON) (FSE: 6UF) (“NeonMind“), a psychedelic drug development company, is pleased to announce its c...
CFN Media

Jan 19, 2021
Article Image

Awakn Strengthens Scientific and Medical Leadership with Appointment of Chief Science Officer and Head of Ketamine Alcohol Use Disorder Practice

Awakn Life Sciences Inc., a biotechnology company focused on research, development and delivery of psychedelic medicines for the treatment of mental health conditions, today announced the appointme...
CFN Media

Jan 19, 2021
Article Image

CYBIN Announces Upsize to Previously Announced Bought Deal Offering

Cybin Inc. (NEO: CYBN) (“Cybin“), a life sciences company focused on psychedelic pharmaceutical therapies, is pleased to announce today that, due to strong demand, it has agreed with a syndicate of...
CFN Media

Jan 19, 2021
Article Image

Entheon Biomedical Partners with Divergence Neuro Technologies Inc. for Predictive Biomarker Platform Development

Entheon Biomedical Corp. (CSE: ENBI) (FSE: 1XU1) (OTC Pink: ENTBF) (“Entheon“), a biotechnology company focused on developing psychedelic medicines to treat addiction, announced a partnership with ...
CFN Media

Jan 19, 2021
Article Image

PharmaTher Signs Exclusive Worldwide License Agreement for Patented Ketamine Formulation Targeting Mental Health, Neurological and Pain Disorders

Newscope Capital Corporation (CSE: PHRM) (OTCQB: PHRRF), who through its wholly-owned subsidiary, PharmaTher Inc. (“PharmaTher”), is a specialty life sciences company focused on the research and de...
CFN Media

Jan 19, 2021